Traws Pharma
TRAW
33 hedge funds and large institutions have $6.83M invested in Traws Pharma in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 7 closing their positions.
98% more capital invested
Capital invested by funds: $3.45M → $6.83M (+$3.38M)
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
10% more funds holding
Funds holding: 30 → 33 (+3)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$411K |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
+$360K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$119K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$86.9K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$70.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$108K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$105K |
| 3 |
QP
Quilter Plc
London,
United Kingdom
|
-$67K |
| 4 |
Jane Street
New York
|
-$32K |
| 5 |
Squarepoint
New York
|
-$27K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
9WM
26
9258 Wealth Management
Blue Ash,
Ohio
| $7K | – | – | – |
|
|
GG
27
Golden Green
Seneca,
South Carolina
| $6K | +$3.71K | +32 | New |
|
28
Cambridge Investment Research Advisors
Fairfield,
Iowa
| $5K | +$3.37K | +29 | New |
|
29
Rockefeller Capital Management
New York
| $3K | -$929 | -8 | -26% |
|
30
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
|
PCM
31
Perkins Capital Management
Wayzata,
Minnesota
| – | -$105K | -1,000 | Closed |
|
|
32
Jane Street
New York
| – | -$32K | -305 | Closed |
|
|
JCM
33
Jacobi Capital Management
Pittston,
Pennsylvania
| – | -$22K | -213 | Closed |
|
34
JP Morgan Chase
New York
| – | -$17K | -166 | Closed |
|
35
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$15K | -139 | Closed |
|
36
Two Sigma Advisers
New York
| – | -$5K | -52 | Closed |
|
|
IAIM
37
International Assets Investment Management
Orlando,
Florida
| – | +$232 | +2 | New |
|
TRAW Hedge Fund Activity: Q4 2020 in Review
33 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Traws Pharma (TRAW) for Q4 2020, worth a combined $6.83M — up 98% from $3.45M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new TRAW positions and 7 closed out — a net gain of 4 holders — while 6 added to existing stakes and 8 trimmed.
The largest buyer was Vanguard Group, adding an estimated $411K. The largest seller was HRT Financial, cutting an estimated $108K.
- 33 institutional investors held Traws Pharma (TRAW) as of Q4 2020, up from 30 in Q3 2020.
- Funds reported $6.83M of Traws Pharma stock for Q4 2020, up 98% quarter-over-quarter.
- 11 funds opened new Traws Pharma positions in Q4 2020 and 7 closed out, a net change of +4 holders.
- The largest Traws Pharma buyer in Q4 2020 was Vanguard Group, an estimated $411K added.
- The largest Traws Pharma seller in Q4 2020 was HRT Financial, an estimated $108K sold.
Based on aggregated 13F filings for Q4 2020.